Sign in

CIK 0000921299

  • Non-accelerated filer
  • Smaller reporting company

KYNTRA BIO, INC.

Sign in to watch
Ticker
KYNB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770357827
Phone
+1 415-978-1200
Business address
350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
Former names
FIBROGEN INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-03-19 KEARNS THOMAS F JR Director Exercise or conversion · Stock Option (Right to Buy) −6,000 0
2020-03-19 Chung Christine SVP, China Operations Exercise or conversion +7,345 $25.40 $187K 166,358
2020-03-19 Chung Christine SVP, China Operations Sale −300 $23.93 $7K 166,058
2020-03-19 Chung Christine SVP, China Operations Sale −830 $25.32 $21K 165,228
2020-03-19 Chung Christine SVP, China Operations Sale −6,215 $26.08 $162K 159,013
2020-03-19 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −7,345 34,719
2020-03-18 Chung Christine SVP, China Operations Exercise or conversion +400 $25.40 $10K 162,918
2020-03-18 Chung Christine SVP, China Operations Sale −905 $23.69 $21K 162,013
2020-03-18 Chung Christine SVP, China Operations Sale −1,500 $24.56 $37K 160,513
2020-03-18 Chung Christine SVP, China Operations Sale −1,500 $25.68 $39K 159,013
2020-03-18 Chung Christine SVP, China Operations Exercise or conversion · Stock Option (Right to Buy) −400 42,064
2020-03-17 Chung Christine SVP, China Operations Grant or award +40,000 162,518
2020-03-17 Chung Christine SVP, China Operations Grant or award · Stock Option (Right to Buy) +66,250 66,250
2020-03-17 Yu K Peony Chief Medical Officer Grant or award +45,000 211,541
2020-03-17 Yu K Peony Chief Medical Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2020-03-17 Kouchakji Elias SVP, Clinical Dev, Drug Safety Grant or award +37,500 132,191
2020-03-17 Kouchakji Elias SVP, Clinical Dev, Drug Safety Grant or award · Stock Option (Right to Buy) +62,500 62,500
2020-03-17 Cotroneo Pat SVP, Finance and CFO Grant or award +40,000 276,466
2020-03-17 Cotroneo Pat SVP, Finance and CFO Grant or award · Stock Option (Right to Buy) +66,250 66,250
2020-03-16 Yu K Peony Chief Medical Officer Exercise or conversion +3,750 $19.39 $73K 166,541

Page 22 of 33 · 651 trades